Cationic liposomes as vaccine adjuvants

References

• Joseph A, Itskovitz-Cooper N, Samira S et al. A new intranasal influenza vaccine based on a novel polycationic lipid–ceramide carbamoyl–spermine (CCS) I. Immunogenicity and efficacy studies in mice. Vaccine24(18), 3990–4006 (2006).
   PubMed Web of Science ®Google Scholar
• Latif N, Bachhawat BK. The effect of surface charges of liposomes in immunopotentiation. Biosci. Rep.4(2), 99–107 (1984).
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Kunisawa J, Hayashi A et al. Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochem. Biophys. Res. Commun.240(3), 793–797 (1997).
   PubMed Web of Science ®Google Scholar
• Perrie Y, Frederik PM, Gregoriadis G. Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine19(23–24), 3301–3310 (2001).
   PubMed Web of Science ®Google Scholar
• Shi Y, Rock KL. Cell death releases endogenous adjuvants that selectively enhance immune surveillance of particulate antigens. Eur. J. Immunol.32(1), 155–162 (2002).
   PubMed Web of Science ®Google Scholar
• Foged C, Arigita C, Sundblad A, Jiskoot W, Storm G, Frokjaer S. Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition. Vaccine22(15–16), 1903–1913 (2004).
   PubMed Web of Science ®Google Scholar
• Allison AG, Gregoriadis G. Liposomes as immunological adjuvants. Nature252(5480), 252 (1974).
   PubMed Web of Science ®Google Scholar
• Vangasseri DP, Cui Z, Chen W, Hokey DA, Falo LD Jr, Huang L. Immunostimulation of dendritic cells by cationic liposomes. Mol. Membr. Biol.23(5), 385–395 (2006).
   PubMed Web of Science ®Google Scholar
• Mazumdar T, Anam K, Ali N. A mixed Th1/Th2 response elicited by a liposomal formulation of leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice. Vaccine22(9–10), 1162–1171 (2004).
   PubMed Web of Science ®Google Scholar
• Bomford R. The adjuvant activity of fatty acid esters. The role of acyl chain length and degree of saturation. Immunology44(1), 187–192 (1981).
   PubMed Web of Science ®Google Scholar
• Kuramoto T, Nishikawa M, Thanaketpaisarn O, Okabe T, Yamashita F, Hashida M. Use of lipoplex-induced nuclear factor-κB activation to enhance transgene expression by lipoplex in mouse lung. J. Gene Med.8(1), 53–62 (2006).
   PubMed Web of Science ®Google Scholar
• Zaks K, Jordan M, Guth A et al. Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes. J. Immunol.176(12), 7335–7345 (2006).
   PubMed Web of Science ®Google Scholar
• Mitchell LA, Joseph A, Kedar E, Barenholz Y, Galun E. Mucosal immunization against hepatitis A: antibody responses are enhanced by co-administration of synthetic oligodeoxynucleotides and a novel cationic lipid. Vaccine24(25), 5300–5310 (2006).
   PubMed Web of Science ®Google Scholar
• Simberg D, Weisman S, Talmon Y, Barenholz Y. DOTAP (and other cationic lipids): chemistry, biophysics, and transfection. Crit. Rev. Ther. Drug Carrier Syst.21(4), 257–317 (2004).
   PubMed Web of Science ®Google Scholar
• Perrie Y, McNeil S, Vangala A. Liposome-mediated DNA immunisation via the subcutaneous route. J. Drug Target.11(8–10), 555–563 (2003).
   PubMed Web of Science ®Google Scholar
• Vangala A, Bramwell VW, McNeil S, Christensen D, Agger EM, Perrie Y. Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen. J. Control. Release119(1), 102–110 (2007).
   PubMed Web of Science ®Google Scholar
• Bei R, Guptill V, Masuelli L et al. The use of a cationic liposome formulation (DOTAP) mixed with a recombinant tumor-associated antigen to induce immune responses and protective immunity in mice. J. Immunother.21(3), 159–169 (1998).
   PubMed Web of Science ®Google Scholar
• Walker C, Selby M, Erickson A, Cataldo D, Valensi JP, Van Nest GV. Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway. Proc. Natl Acad. Sci. USA89(17), 7915–7918 (1992).
   PubMed Web of Science ®Google Scholar
• Rejman J, Conese M, Hoekstra D. Gene transfer by means of lipo- and polyplexes: role of clathrin and caveolae-mediated endocytosis. J. Liposome Res.16(3), 237–247 (2006).
   PubMed Web of Science ®Google Scholar
• Zuhorn IS, Kalicharan R, Hoekstra D. Lipoplex-mediated transfection of mammalian cells occurs through the cholesterol-dependent clathrin-mediated pathway of endocytosis. J. Biol. Chem.277(20), 18021–18028 (2002).
   PubMed Web of Science ®Google Scholar
• Cui Z, Han SJ, Vangasseri DP, Huang L. Immunostimulation mechanism of LPD nanoparticle as a vaccine carrier. Mol. Pharm.2(1), 22–28 (2005).
   PubMed Web of Science ®Google Scholar
• Yan W, Chen W, Huang L. Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines. Mol. Immunol.44(15), 3672–3681 (2007).
   PubMed Web of Science ®Google Scholar
• Hamm S, Heit A, Koffler M et al. Immunostimulatory RNA is a potent inducer of antigen-specific cytotoxic and humoral immune response in vivo. Int. Immunol.19(3), 297–304 (2007).
   PubMed Web of Science ®Google Scholar
• Loseke S, Grage-Griebenow E, Heine H et al. In vitro-generated viral double-stranded RNA in contrast to polyinosinic:polycytidylic acid induces interferon-α in human plasmacytoid dendritic cells. Scand. J. Immunol.63(4), 264–274 (2006).
   PubMed Web of Science ®Google Scholar
• Gao X, Huang L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun.179(1), 280–285 (1991).
   PubMed Web of Science ®Google Scholar
• Brunel F, Darbouret A, Ronco J. Cationic lipid DC-Chol induces an improved and balanced immunity able to overcome the unresponsiveness to the hepatitis B vaccine. Vaccine17, 2192–2203 (1999).
   PubMed Web of Science ®Google Scholar
• Sanchez V, Gimenez S, Haensler J et al. Formulations of single or multiple H. pylori antigens with DC Chol adjuvant induce protection by the systemic route in mice. Optimal prophylactic combinations are different from therapeutic ones. FEMS Immunol. Med. Microbiol.30(2), 157–165 (2001).
   PubMedGoogle Scholar
• Guy B, Pascal N, Francon A et al. Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine. Vaccine19(13–14), 1794–805 (2001).
   PubMed Web of Science ®Google Scholar
• Hattori Y, Kawakami S, Suzuki S, Yamashita F, Hashida M. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. Biochem. Biophys. Res. Commun.317(4), 992–999 (2004).
   PubMed Web of Science ®Google Scholar
• Cremel M, Hamzeh-Cognasse H, Genin C, Delezay O. Female genital tract immunization: evaluation of candidate immunoadjuvants on epithelial cell secretion of CCL20 and dendritic/Langerhans cell maturation. Vaccine24(29–30), 5744–5754 (2006).
   PubMed Web of Science ®Google Scholar
• Davidsen J, Rosenkrands I, Christensen D et al. Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6´-dibehenate) – a novel adjuvant inducing both strong CMI and antibody responses. Biochim. Biophys. Acta1718(1–2), 22–31 (2005).
   PubMed Web of Science ®Google Scholar
• Feitosa E, Barreleiro PCA, Olofsson G. Phase transition in dioctadecyldimethylammonium bromide and chloride vesicles prepared by different Methods Chem. Phys. Lipids105(2), 201–213 (2000).
   PubMed Web of Science ®Google Scholar
• Gall D. The adjuvant activity of aliphatic nitrogenous bases. Immunology11(4), 369–386 (1966).
   PubMed Web of Science ®Google Scholar
• Dailey MO, Hunter RL. The role of lipid in the induction of hapten-specific delayed hypersensitivity and contact sensitivity. J. Immunol.112(4), 1526–1534 (1974).
   PubMed Web of Science ®Google Scholar
• Snippe H, Belder M, Willers JM. Dimethyl diotadecyl ammonium bromide as adjuvant for delayed hypersensitivity in mice. Immunology33(6), 931–936 (1977).
   PubMed Web of Science ®Google Scholar
• Katz D, Lehrer S, Galan O et al. Unique immunomodulating properties of dimethyl dioctadecyl ammonium bromide (DDA) in experimental viral vaccines. Adv. Exp. Med. Biol.397, 115–125 (1996).
   PubMedGoogle Scholar
• Kraaijeveld CA, la Riviere G, Benaissa-Trouw BJ, Jansen J, Harmsen T, Snippe H. Effect of the adjuvant dimethyl dioctadecyl ammonium bromide on the humoral and cellular immune responses to encephalomyocarditis virus. Antiviral Res.3(3), 137–149 (1983).
   PubMed Web of Science ®Google Scholar
• Klinguer-Hamour C, Libon C, Plotnicky-Gilquin H et al. DDA adjuvant induces a mixed Th1/Th2 immune response when associated with BBG2Na, a respiratory syncytial virus potential vaccine. Vaccine20(21–22), 2743–2751 (2002).
   PubMed Web of Science ®Google Scholar
• Lindblad EB, Elhay MJ, Silva R, Appelberg R, Andersen P. Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect. Immun.65(2), 623–629 (1997).
   PubMed Web of Science ®Google Scholar
• Andersen P. The T cell response to secreted antigens of Mycobacterium tuberculosis. Immunobiology191(4–5), 537–547 (1994).
   PubMed Web of Science ®Google Scholar
• Prager MD, Gordon WC. Enhanced response to chemoimmunotherapy and immunoprophylaxis with the use of tumor-associated antigens with a lipophilic agent. Cancer Res.38(7), 2052–2057 (1978).
   PubMed Web of Science ®Google Scholar
• Stanfield JP, Gall D, Bracken PM. Single-dose antenatal tetanus immunisation. Lancet301(7797), 215–219 (1973).
   Google Scholar
• Veronesi R, Correa A, Alterio D. Single dose immunization against tetanus. Promising results in human trials. Rev. Inst. Med. Trop. (Sao Paulo)12(1), 46–54 (1970).
   PubMedGoogle Scholar
• Hilgers LA, Snippe H. DDA as an immunological adjuvant. Res. Immunol.143(5), 494–503 (1992).
   PubMedGoogle Scholar
• Larsen ST, Hansen R, Hammer M, Tegner U, Poulsen OM, Nielsen GD. Adjuvant effect of quaternary ammonium compounds in a murine model. Toxicol. Lett.151(2), 389–398 (2004).
   PubMed Web of Science ®Google Scholar
• Klinguer C, Beck A, De-Lys P et al. Lipophilic quaternary ammonium salt acts as a mucosal adjuvant when co-administered by the nasal route with vaccine antigens. Vaccine19(30), 4236–4244 (2001).
   PubMed Web of Science ®Google Scholar
• Korsholm KS, Agger EM, Foged C et al. The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes. Immunology121(2), 216–226 (2007).
   PubMed Web of Science ®Google Scholar
• Mounkes LC, Zhong W, Cipres-Palacin G, Heath TD, Debs RJ. Proteoglycans mediate cationic liposome–DNA complex-based gene delivery in vitro and in vivo. J. Biol. Chem.273(40), 26164–26170 (1998).
   PubMed Web of Science ®Google Scholar
• Rosenkrands I, Agger EM, Olsen AW et al. Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system. Infect. Immun.73(9), 5817–5826 (2005).
   PubMed Web of Science ®Google Scholar
• Guy B. The perfect mix: recent progress in adjuvant research. Nat. Rev. Microbiol.5, 505–517 (2007).
   PubMed Web of Science ®Google Scholar
• Qureshi N, Mascagni P, Ribi E, Takayama K. Monophosphoryl lipid A obtained from lipopolysaccharides of Salmonella minnesota R595. Purification of the dimethyl derivative by high performance liquid chromatography and complete structural determination. J. Biol. Chem.260(9), 5271–5278 (1985).
   PubMed Web of Science ®Google Scholar
• Ribi E, Cantrell JL, Takayama K, Qureshi N, Peterson J, Ribi HO. Lipid A and immunotherapy. Rev. Infect. Dis.6(4), 567–572 (1984).
   PubMedGoogle Scholar
• Stewart VA, Walsh DS, McGrath SM et al. Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS,S in rhesus macaques. Vaccine24(42–43), 6493–6502 (2006).
   PubMed Web of Science ®Google Scholar
• Tsenova L, Harbacheuski R, Moreira AL et al. Evaluation of the Mtb72F polyprotein vaccine in a rabbit model of tuberculous meningitis. Infect. Immun.74(4), 2392–2401 (2006).
   PubMed Web of Science ®Google Scholar
• Brandt L, Elhay M, Rosenkrands I, Lindblad EB, Andersen P. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect. Immun.68(2), 791–795 (2000).
   PubMed Web of Science ®Google Scholar
• Holten-Andersen L, Doherty TM, Korsholm KS, Andersen P. Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines. Infect. Immun.72(3), 1608–1617 (2004).
   PubMed Web of Science ®Google Scholar
• Olsen AW, Williams A, Okkels LM, Hatch G, Andersen P. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B, ESAT-6 in the aerosol guinea pig model. Infect. Immun.72(10), 6148–6150 (2004).
   PubMed Web of Science ®Google Scholar
• Langermans JA, Doherty TM, Vervenne RA et al. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B, ESAT-6. Vaccine23(21), 2740–2750 (2005).
   PubMed Web of Science ®Google Scholar
• Doherty TM, Olsen AW, van Pinxteren L, Andersen P. Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis. Infect. Immun.70(6), 3111–3121 (2002).
   PubMed Web of Science ®Google Scholar
• Krieg AM, Yi AK, Hartmann G. Mechanisms and therapeutic applications of immune stimulatory CPG DNA. Pharmacol. Ther.84(2), 113–120 (1999).
   PubMed Web of Science ®Google Scholar
• Dalpke A, Frank J, Peter M, Heeg K. Activation of Toll-like receptor 9 by DNA from different bacterial species. Infect. Immun.74(2), 940–946 (2006).
   PubMed Web of Science ®Google Scholar
• Gursel I, Gursel M, Ishii KJ, Klinman DM. Sterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotides. J. Immunol.167(6), 3324–3328 (2001).
   PubMed Web of Science ®Google Scholar
• Whitmore M, Li S, Huang L. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene Ther.6(11), 1867–1875 (1999).
   PubMed Web of Science ®Google Scholar
• Jiao X, Wang RY, Qiu Q, Alter HJ, Shih JW. Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen, CpG with cationic liposomes. J. Gen. Virol.85(6), 1545–1553 (2004).
   PubMed Web of Science ®Google Scholar
• Salem ML, El-Naggar SA, Kadima A, Gillanders WE, Cole DJ. The adjuvant effects of the Toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu. Vaccine24(24), 5119–5132 (2006).
   PubMed Web of Science ®Google Scholar
• Durand V, Wong SY, Tough DF, Le Bon A. Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-α/β. Immunol. Cell. Biol.82(6), 596–602 (2004).
   PubMed Web of Science ®Google Scholar
• Fujimura T, Nakagawa S, Ohtani T, Ito Y, Aiba S. Inhibitory effect of the polyinosinic–polycytidylic acid/cationic liposome on the progression of murine B16F10 melanoma. Eur. J. Immunol.36(12), 3371–80 (2006).
   PubMed Web of Science ®Google Scholar
• Ellouz F, Adam A, Ciorbaru R, Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun.59(4), 1317–1325 (1974).
   PubMed Web of Science ®Google Scholar
• Woodard LF, Toone NM, McLaughlin CA. Comparison of muramyl dipeptide, trehalose dimycolate, and dimethyl dioctadecyl ammonium bromide as adjuvants in Brucella abortus 45/20 vaccines. Infect. Immun.30(2), 409–412 (1980).
   PubMed Web of Science ®Google Scholar
• Girardin SE, Boneca IG, Viala J et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem.278(11), 8869–8872 (2003).
   PubMed Web of Science ®Google Scholar
• Tada H, Aiba S, Shibata K, Ohteki T, Takada H. Synergistic effect of Nod1, Nod2 agonists with Toll-like receptor agonists on human dendritic cells to generate interleukin-12, T helper type 1 cells. Infect. Immun.73(12), 7967–7976 (2005).
   PubMed Web of Science ®Google Scholar
• Dzata GK, Wyckoff JH 3rd, Confer AW. Immunopotentiation of cattle vaccinated with a soluble Brucella abortus antigen with low LPS content: an analysis of cellular and humoral immune responses. Vet. Microbiol.29(1), 15–26 (1991).
   PubMed Web of Science ®Google Scholar
• Bekierkunst A, Yarkoni E, Flechner I, Morecki S, Vilkas E, Lederer E. Immune response to sheep red blood cells in mice pretreated with mycobacterial fractions. Infect. Immun.4(3), 256–263 (1971).
   PubMed Web of Science ®Google Scholar
• Lima VM, Bonato VL, Lima KM et al. Role of trehalose dimycolate in recruitment of cells and modulation of production of cytokines, NO in tuberculosis. Infect. Immun.69(9), 5305–5312 (2001).
   PubMed Web of Science ®Google Scholar
• Silva CL, Ekizlerian SM, Fazioli RA. Role of cord factor in the modulation of infection caused by mycobacteria. Am. J. Pathol.118(2), 238–247 (1985).
   PubMed Web of Science ®Google Scholar
• Ryll R, Watanabe K, Fujiwara N et al. Mycobacterial cord factor, but not sulfolipid, causes depletion of NKT cells and upregulation of CD1d1 on murine macrophages. Microbes Infect.3(8), 611–619 (2001).
   PubMed Web of Science ®Google Scholar
• Oswald IP, Dozois CM, Petit JF, Lemaire G. Interleukin-12 synthesis is a required step in trehalose dimycolate-induced activation of mouse peritoneal macrophages. Infect. Immun.65(4), 1364–1369 (1997).
   PubMed Web of Science ®Google Scholar
• Geisel RE, Sakamoto K, Russell DG, Rhoades ER. In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette–Guerin is due principally to trehalose mycolates. J. Immunol.174(8), 5007–5015 (2005).
   PubMed Web of Science ®Google Scholar
• Lima KM, Santos SA, Lima VM, Coelho-Castelo AA, Rodrigues JM Jr, Silva CL. Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis. Gene Ther.10(8), 678–685 (2003).
   PubMed Web of Science ®Google Scholar
• Masihi KN, Lange W, Brehmer W, Ribi E. Immunobiological activities of nontoxic lipid A: enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects. Int. J. Immunopharmacol.8(3), 339–345 (1986).
   PubMed Web of Science ®Google Scholar
• Coelho EA, Tavares CA, Lima Kde M, Silva CL, Rodrigues JM Jr, Fernandes AP. Mycobacterium hsp65 DNA entrapped into TDM-loaded PLGA microspheres induces protection in mice against Leishmania (Leishmania) major infection. Parasitol. Res.98(6), 568–575 (2006).
   PubMed Web of Science ®Google Scholar
• Vosika GJ, Schmidtke JR, Goldman A, Ribi E, Parker R, Gray GR. Intralesional immunotherapy of malignant melanoma with Mycobacterium smegmatis cell wall skeleton combined with trehalose dimycolate (P3). Cancer44(2), 495–503 (1979).
   PubMed Web of Science ®Google Scholar
• Hunter RL, Olsen M, Jagannath C, Actor JK. Trehalose 6,6´-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice. Am. J. Pathol.168(4), 1249–1261 (2006).
   PubMed Web of Science ®Google Scholar
• Fujita Y, Okamoto Y, Uenishi Y, Sunagawa M, Uchiyama T, Yano I. Molecular and supra-molecular structure related differences in toxicity and granulomatogenic activity of mycobacterial cord factor in mice. Microb. Pathog.43(1), 10–21 (2007).
   PubMed Web of Science ®Google Scholar
• Nishizawa M, Yamamoto H, Imagawa H et al. Efficient syntheses of a series of trehalose dimycolate (TDM)/trehalose dicorynomycolate (TDCM) analogues and their interleukin-6 level enhancement activity in mice sera. J. Org. Chem.72(5), 1627–1633 (2007).
   PubMed Web of Science ®Google Scholar
• Olds GR, Chedid L, Lederer E, Mahmoud AA. Induction of resistance to Schistosoma mansoni by natural cord factor and synthetic lower homologues. J. Infect. Dis.141(4), 473–478 (1980).
   PubMed Web of Science ®Google Scholar
• Yarkoni E, Rapp HJ, Polonsky J, Lederer E. Immunotherapy with an intralesionally administered synthetic cord factor analogue. Int. J. Cancer22(5), 564–569 (1978).
   PubMed Web of Science ®Google Scholar
• Pimm MV, Baldwin RW, Polonsky J, Lederer E. Immunotherapy of an ascitic rat hepatoma with cord factor (trehalose-6,6´-dimycolate) and synthetic analogues. Int. J. Cancer24(6), 780–785 (1979).
   PubMed Web of Science ®Google Scholar
• Vangala A, Kirby D, Rosenkrands I, Agger EM, Andersen P, Perrie Y. A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice. J. Pharm. Pharmacol.58(6), 787–799 (2006).
   PubMed Web of Science ®Google Scholar
• Gavin AL, Hoebe K, Duong B et al. Adjuvant-enhanced antibody responses in the absence of Toll-like receptor signaling. Science314(5807), 1936–1938 (2006).
   PubMed Web of Science ®Google Scholar
• Valmori D, Souleimanian NE, Tosello V et al. Vaccination with NY-ESO-1 protein, CpG in Montanide induces integrated antibody/Th1 responses, CD8 T cells through cross-priming. Proc. Natl Acad. Sci. USA104(21), 8947–8952 (2007).
   PubMed Web of Science ®Google Scholar
• Christensen D, Foged C, Rosenkrands I, Nielsen HM, Andersen P, Agger EM. Trehalose preserves DDA/TDB liposomes and their adjuvant effect during freeze-drying. Biochim. Biophys. Acta Biomembr.1768(9), 2120–2129 (2007).
   PubMed Web of Science ®Google Scholar
• Mohammed AR, Bramwell VW, Coombes AG, Perrie Y. Lyophilisation and sterilisation of liposomal vaccines to produce stable and sterile products. Methods40(1), 30–38 (2006).
   PubMed Web of Science ®Google Scholar